Biotechnology, Pharmaceutical and Life Science Reports and Courses

Main Pages

Best Selling Products

BioNewsCast Press Release Distribution Service

Vaccine Technology 2009 Conference

Veterinary Diagnostics Markets

Practical Guide to Finding Partners in Pharma & Biotech, 2nd edition

Royalty Financing Agreements in Pharma, Biotech and Diagnostics

New Products

Attention Deficit Hyperactivity Disorder: Diagnosis and Treatment

Bioinformatics Market Potential

Biotechnology in the European Union; Trends, Investing & Country Profiles

China Pharmaceutical Industry: Analysis and Market Trends

European Generic Drug Market Potential

Global Biotechnology Markets Trends

Strategic Alliances in World Pharma and Biotech Markets

Understanding China's Chemical Industry

Understanding Genomics and Global Health Impacts

Understanding Pharmacogenomics

BioPortfolio | Kalorama Reports | Congestive Heart Failure: Major World Markets, Volume II: Devices (Pacemaker, ICD, LVAD and Artificial Heart Markets)

Congestive Heart Failure: Major World Markets, Volume II: Devices (Pacemaker, ICD, LVAD and Artificial Heart Markets)

Congestive heart failure, a condition caused by a malfunctioning heart that is unable to pump enough blood and oxygen to meet the body’s needs, is an increasingly important cause of cardiovascular morbidity and mortality. With improvements in the care of other cardiac conditions, more patients have developed dilated cardiomyopathy, which is the final common pathway for many cardiac illnesses and a common cause of congestive heart failure.

Kalorama Information's Congestive Heart Failure, Major World Markets series looks at markets for CHF treatment in the United States, Europe, Japan and the Rest of the World. Volume II of this series looks at markets for device management of this disease in the following key categories:

Pacemakers

Left Ventricular Assistance Devices (LVADs)

Implantable Cardioverter/Defibrillators (ICDs)

Artificial Hearts

The report offers revenue breakdowns the following world markets:

Europe

Japan

Rest of World

In addition to market forecasts and current market information, this report contains a thorough review of products available on the market and profiles of key companies, including:

Abbott Laboratories

Abiomed, Inc.

Ambu, USA

Aortech International, plc

Arrow International

Atrium Medical Corporation

ATS Medical, Inc.

Bacchus Vascular, Inc.

Berlin Heart AG

Biophan Technologies, Inc.

Biosensors International

Biotronik, Inc.

Boston Scientific

CardiacAssist, Inc.

Cardiac Science Corporation

Cardiogenesis Corporation

Cordis Corporation/Biologics Delivery Systems

CoreValve, Inc.

CryoCath Technologies, Inc.

Cryocor, Inc.

Datascope

Defibtech, LLC

Deltex Medical

Heartlab

Impulse Dynamics USA, Inc.

MedicalCV, Inc.

Medtronic, Inc.

Orqis Medical Corporation

Sorin SpA

Stereotaxis, Inc.

St. Jude Medical, Inc.

Teleflex Medical

Terumo Heart, Inc.

Thoratec Corporation

Ventracor, Inc.

Volcano Corporation

As part of Kalorama Information's methodology, analyst estimates are computed with intensive research of secondary data and literature, and primary research involving interviews of experts are used to test assumptions and validate models.

Product managers, business development executives, marketing executives and planners are among those who will benefit from this resource.

February 1, 2008 250+ Pages

Table of Contents
Sample Pages (PDF)

Price

BioPortfolio uses RBS Worldpay Secure Server for credit card transactions